A/Prof Lucinda Morris

Experts / A/Prof Lucinda Morris

A/Prof Lucinda Morris

Radiation Oncologist, Western Sydney Local Health District; Founding Co-Chair Targeting Cancer

Assoicate Professor is a Radiation Oncologist specialising in lymphoma, breast and upper GI cancer. Clinical researcher and international expert in geriatric radiation oncology. Passionate about global advocacy and education in radiation oncology. Lucinda works at Western Sydney Local Health District (Westmead/Blacktown).

Revolutionising curative treatment for prostate cancer

In today’s podcast, experts Prof Sandra Turner and A/Prof Lucinda Morris discuss radiation therapy as a key curative option for prostate cancer and its role in patient referrals.

Oncology

Podcasts

Radiation therapy vs surgery for prostate cancer

Major advances in external beam radiotherapy means that it achieves similar long term outcomes to radical prostatectomy with markedly less incontinence, erectile dysfunction at lower costs since it’s fully funded by Medicare

Oncology

Monographs

Modern Radiation Therapy and Hormone Therapy for Localised Prostate Cancer

This article discusses the importance of referral of patients with prostate cancer for consideration of radiation therapy if active treatment is considered.

Modern Radiation Therapy and Hormone Therapy for Localised Prostate Cancer

This article discusses the importance of referral of patients with prostate cancer for consideration of radiation therapy if active treatment is considered.

By Prof Sandra Turner, A/Prof Lucinda Morris

Monographs

Oncology

Radiation therapy vs surgery for prostate cancer

Major advances in external beam radiotherapy means that it achieves similar long term outcomes to radical prostatectomy with markedly less incontinence, erectile dysfunction at lower costs since it’s fully funded by Medicare

By Prof Sandra Turner, A/Prof Lucinda Morris

Podcasts

Oncology

Revolutionising curative treatment for prostate cancer

In today’s podcast, experts Prof Sandra Turner and A/Prof Lucinda Morris discuss radiation therapy as a key curative option for prostate cancer and its role in patient referrals.

By Prof Sandra Turner, A/Prof Lucinda Morris

Podcasts

Men's health

A/Prof Lucinda Morris

Radiation Oncologist, Western Sydney Local Health District; Founding Co-Chair Targeting Cancer

More from this expert

Revolutionising curative treatment for prostate cancer

In today’s podcast, experts Prof Sandra Turner and A/Prof Lucinda Morris discuss radiation therapy as a key curative option for prostate cancer and its role in patient referrals.

Radiation therapy vs surgery for prostate cancer

Major advances in external beam radiotherapy means that it achieves similar long term outcomes to radical prostatectomy with markedly less incontinence, erectile dysfunction at lower costs since it’s fully funded by Medicare

Modern Radiation Therapy and Hormone Therapy for Localised Prostate Cancer

This article discusses the importance of referral of patients with prostate cancer for consideration of radiation therapy if active treatment is considered.

Modern Radiation Therapy and Hormone Therapy for Localised Prostate Cancer

This article discusses the importance of referral of patients with prostate cancer for consideration of radiation therapy if active treatment is considered.

Radiation therapy vs surgery for prostate cancer

Major advances in external beam radiotherapy means that it achieves similar long term outcomes to radical prostatectomy with markedly less incontinence, erectile dysfunction at lower costs since it’s fully funded by Medicare

Revolutionising curative treatment for prostate cancer

In today’s podcast, experts Prof Sandra Turner and A/Prof Lucinda Morris discuss radiation therapy as a key curative option for prostate cancer and its role in patient referrals.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

In the upcoming Healthed Webcast

Dementia Chronic Disease - Practical Advice

We invite you to join the upcoming Healthed webcast where Prof Macrae speak on how GPs can suspect, assess and manage hereditary colorectal cancer risk.

Tuesday 2nd September, 7pm AEST

A/Prof Mark Yates

We invite you to join the upcoming Healthed webcast where Prof Macrae speak on how GPs can suspect, assess and manage hereditary colorectal cancer risk.

Tuesday 2nd September, 7pm AEST

A/Prof Lucinda Morris

Radiation Oncologist, Western Sydney Local Health District; Founding Co-Chair Targeting Cancer

More from this expert

In today’s podcast, experts Prof Sandra Turner and A/Prof Lucinda Morris discuss radiation therapy as a key curative option for prostate cancer and its role in patient referrals.

Major advances in external beam radiotherapy means that it achieves similar long term outcomes to radical prostatectomy with markedly less incontinence, erectile dysfunction at lower costs since it’s fully funded by Medicare

This article discusses the importance of referral of patients with prostate cancer for consideration of radiation therapy if active treatment is considered.

This article discusses the importance of referral of patients with prostate cancer for consideration of radiation therapy if active treatment is considered.

Major advances in external beam radiotherapy means that it achieves similar long term outcomes to radical prostatectomy with markedly less incontinence, erectile dysfunction at lower costs since it’s fully funded by Medicare

In today’s podcast, experts Prof Sandra Turner and A/Prof Lucinda Morris discuss radiation therapy as a key curative option for prostate cancer and its role in patient referrals.

Get the app

Site

Company

Connect

Legal

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

We invite you to join the upcoming Healthed webcast where Prof Macrae speak on how GPs can suspect, assess and manage hereditary colorectal cancer risk. Tuesday 2nd September, 7pm AEST

A/Prof Mark Yates

We invite you to join the upcoming Healthed webcast where Prof Macrae speak on how GPs can suspect, assess and manage hereditary colorectal cancer risk. Tuesday 2nd September, 7pm AEST

We invite you to join the upcoming Healthed webcast where Prof Macrae speak on how GPs can suspect, assess and manage hereditary colorectal cancer risk.

Tuesday 2nd September, 7pm AEST

We invite you to join the upcoming Healthed webcast where Prof Macrae speak on how GPs can suspect, assess and manage hereditary colorectal cancer risk.

Tuesday 2nd September, 7pm AEST